drugset / Trial / NCT06773767
Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid® at Steady-state.
RandomizedCrossoverSingle-blindOther
Summary
Two way, two parallel groups, crossover study to compare the bioavailability of 150 mg and 300 mg trazodone hydrochloride (new polymer) (Angelini Pharma S.p.A.) vs. 150 mg and 300 mg trazodone hydrochloride Contramid® (Angelini Pharma S.p.A.) at steady-state in 64 Healthy Volunteers.
Timeline
- Start
- 2024-05-22
- Primary completion
- 2024-08-07
- Completion
- 2024-08-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trazodone | Small molecule | 150 mg | — |
| Subject | Trazodone | Small molecule | 300 mg | — |
Indications
No indication recorded.